# FDA Inspection 845146 - Central Pennsylvania Blood Bank - August 20, 2013

Source: https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/e5970324-a975-4357-9063-13dca0e58a39
Source feed: FDA_Inspections

> FDA Inspection 845146 for Central Pennsylvania Blood Bank on August 20, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 845146
- Company Name: Central Pennsylvania Blood Bank
- Inspection Date: 2013-08-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1006244 - 2017-03-23](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/70ea940b-9c8b-4881-a3ff-d26ef040bd48)
- [FDA Inspection 922507 - 2015-04-16](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/775df697-f6c5-4b70-8d67-7e6c48f1d2da)
- [FDA Inspection 760785 - 2011-11-29](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/c2f0d442-9e97-439c-8d30-7e94fefa0813)
- [FDA Inspection 641517 - 2010-01-28](https://www.keypedia.com/records/fda_inspections/central-pennsylvania-blood-bank/af089ab9-e4b9-40de-accb-090dc6f57234)

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank/db77ebbe-7c22-4bba-8fba-7f5b92a9d41a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d